Results 21 to 30 of about 6,038 (211)

Crotamine-based recombinant immunotoxin targeting HER2 for enhanced cancer cell specificity and cytotoxicity

open access: yes, 2023
Crotamine, one of the major toxins present in the venom of the South American rattlesnake Crotalus durissus terrificus, exhibits potent cytotoxic properties and has been suggested for cancer therapy applications. However, its selectivity for cancer cells
Minh Quan Nguyen   +8 more
core   +1 more source

AN OVERVIEW: IMMUNOTOXIN

open access: yes, 2021
Immunotoxins are hybrid molecules composed of a monoclonal antibody chemically linked to a biologic toxin. The antibody portion of the molecule directs it to a specific antigenic determinant on a target cell; the molecule is then internalized, and a ...
Blessy M.R*, Subash Chandran M.P, Prasobh G.R, Remya S.B, Aparna P, Rohini L M, Varsha V R, Archana L R
core   +1 more source

Antiviral Activity of Ribosome-Inactivating Proteins

open access: yesToxins, 2021
Ribosome-inactivating proteins (RIPs) are rRNA N-glycosylases from plants (EC 3.2.2.22) that inactivate ribosomes thus inhibiting protein synthesis. The antiviral properties of RIPs have been investigated for more than four decades.
Lucía Citores   +2 more
doaj   +1 more source

Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin

open access: yes, 1992
In Hodgkin's disease, Hodgkin and Reed-Sternberg cells consistently express the antigen CD30. We investigated the possible therapeutic role of an immunotoxin prepared by covalent linking of an anti-CD30 monoclonal antibody (Ber-H2) to saporin (SO6), a ...
Sabattini E.   +14 more
core   +2 more sources

Immunotoxins for leukemia

open access: yesBlood, 2014
AbstractUnconjugated monoclonal antibodies that target hematopoietic differentiation antigens have been developed to treat hematologic malignancies. Although some of these have activity against chronic lymphocytic leukemia and hairy cell leukemia, in general, monoclonal antibodies have limited efficacy as single agents in the treatment of leukemia.
Alan S, Wayne   +3 more
openaire   +3 more sources

Optimization of the Refolding Process for Recombinant Anti-EGFR Immunotoxin Produced in the Escherichia coli

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām, 2021
Introduction: Overexpression of the EGFR is associated with carcinogenesis, and it is observed in more than 70% of head and neck cancers. The expression of an immunotoxin against EGFR designed as an alternative to full antibody led to the production of ...
Bahman Akbari
doaj  

Designing a Humanized Immunotoxin Based on HER2 Specific scFv and DFF40 Toxin Against Breast Cancer: An In-Silico Study

open access: yes, 2022
Breast cancer is the most frequent cancer in women worldwide. Human epidermal growth factor receptor 2 (HER2) is a receptor which is overexpressed in breast cancer cells.
Ahmadi, Khadijeh   +21 more
core   +1 more source

Depletion of Alloreactive T-Cells by Anti-CD137-Saporin Immunotoxin

open access: yesCell Transplantation, 2015
Depletion of alloreactive T-lymphocytes from allogeneic bone marrow tansplants may prevent graft-versus-host disease (GVHD) without impairing donor cell engraftment, immunity, and the graft-versus-leukemia (GVL) effect.
Sang C. Lee   +8 more
doaj   +1 more source

Bacteria-derived chimeric toxins as potential anticancer agents

open access: yesFrontiers in Oncology, 2022
Cancer is one of the major causes of death globally, requiring everlasting efforts to develop novel, specific, effective, and safe treatment strategies.
Saeed Khoshnood   +7 more
doaj   +1 more source

Treatment with immunotoxin [PDF]

open access: yesPhilosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 2001
T–cell depletion prior to or beginning at the time of transplantation has been shown to be a valuable adjunct to the induction of immunological unresponsiveness. Both total lymphoid irradiation and anti–lymphocyte globulin have been used for this purpose in experimental models of transplantation as well as in human organ transplant
openaire   +2 more sources

Home - About - Disclaimer - Privacy